T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
AGCO
AGCO
$6.96B
| $3.95M | ﹤0.01% |
33,371
+1,092
| +3% | +$139K |
|
1227
Taysha Gene Therapies
TSHA
$1.92B
| $3.94M | ﹤0.01% |
+1,247,471
| New | +$2.33M |
|
|
FLG
1228
Flagstar Bank National Association
FLG
$5.92B
| $3.93M | ﹤0.01% |
115,459
+7,732
| +7% | +$280K |
|
1229
FIVE9
FIVN
$2.53B
| $3.93M | ﹤0.01% |
61,067
-721
| -1% | -$54K |
|
1230
ITT
ITT
$19.4B
| $3.93M | ﹤0.01% |
40,106
+2,207
| +6% | +$217K |
|
1231
Steven Madden
SHOO
$3.46B
| $3.91M | ﹤0.01% |
123,050
-484
| -0.4% | -$16.1K |
|
1232
Carpenter Technology
CRS
$26.6B
| $3.89M | ﹤0.01% |
57,826
-14,828
| -20% | -$899K |
|
1233
Essential Utilities
WTRG
$11.5B
| $3.88M | ﹤0.01% |
112,905
+4,927
| +5% | +$191K |
|
1234
Guidewire Software
GWRE
$15.2B
| $3.87M | ﹤0.01% |
43,026
-2,095
| -5% | -$175K |
|
|
LIAN
1235
DELISTED
LianBio American Depositary Shares
LIAN
| $3.87M | ﹤0.01% |
2,598,766
-111,448
| -4% | -$212K |
|
1236
Trinity Capital Inc.
TRIN
$1.75B
| $3.87M | ﹤0.01% |
277,819
+88,550
| +47% | +$1.28M |
|
1237
Interactive Brokers
IBKR
$41.4B
| $3.85M | ﹤0.01% |
178,108
+8,004
| +5% | +$178K |
|
1238
Wayfair
W
$13.9B
| $3.84M | ﹤0.01% |
63,453
-886
| -1% | -$61.6K |
|
1239
California Water Service
CWT
$3.1B
| $3.84M | ﹤0.01% |
81,085
+360
| +0.4% | +$18.2K |
|
1240
Jazz Pharmaceuticals
JAZZ
$16B
| $3.83M | ﹤0.01% |
29,548
-681
| -2% | -$90.7K |
|
1241
SoFi Technologies
SOFI
$23.8B
| $3.82M | ﹤0.01% |
478,388
-605,864
| -56% | -$5.33M |
|
1242
National Bank Holdings
NBHC
$1.94B
| $3.81M | ﹤0.01% |
128,004
-31,684
| -20% | -$1.01M |
|
1243
Tetra Tech
TTEK
$9.33B
| $3.81M | ﹤0.01% |
125,135
+8,200
| +7% | +$266K |
|
1244
Omega Healthcare
OHI
$13.9B
| $3.76M | ﹤0.01% |
113,287
-2,228
| -2% | -$71.2K |
|
1245
State Street Blackstone Senior Loan ETF
SRLN
$5.38B
| $3.75M | ﹤0.01% |
89,400
| – | – |
|
|
PPBI
1246
DELISTED
Pacific Premier Bancorp
PPBI
| $3.72M | ﹤0.01% |
170,892
+5,801
| +4% | +$134K |
|
1247
ONE Gas
OGS
$5.09B
| $3.68M | ﹤0.01% |
53,844
+705
| +1% | +$53.3K |
|
|
LNW
1248
DELISTED
Light & Wonder
LNW
| $3.67M | ﹤0.01% |
51,488
+390
| +0.8% | +$28.3K |
|
1249
Gentex
GNTX
$4.99B
| $3.67M | ﹤0.01% |
112,745
-4,320
| -4% | -$138K |
|
1250
Acuity Brands
AYI
$10.8B
| $3.67M | ﹤0.01% |
21,518
+1,121
| +5% | +$183K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.